Phase Space Research

Fabrinet

FN · Investment summary · as of 4 August 2026

Priced slightly ahead of what the business has demonstrated

Portfolio decision
No position
Price · 4 August 2026
$455.83
12-month target
Not determined
Expected return
+4.0%
Next decision point
Date not announced

Business type: Cyclical · cyclical or commodity-sensitive

The business does not meet the quality standard for its economic type.

Investment view

At $455.83, FN requires a 33% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 16%.

FN's operating margin has sat in a 1.1pp band for sixteen quarters while revenue doubled, and management passes scale benefits to customers by design (gross margin 12.71% -> 12.09% across FY2023-25 while revenue rose 29%). Nothing in the filed record supports a margin-expansion thesis.

The value rests on an exit multiple of 18.6x, a terminal operating margin of 8% and a 11.5% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.

The strongest argument against this view: Co-packaged optics removes the assembly step FN is paid for.

Underwriting bridge

QuestionEvidence-based conclusion
What drives the business?FN's operating margin has sat in a 1.1pp band for sixteen quarters while revenue doubled, and management passes scale benefits to customers by design (gross margin 12.71% -> 12.09% across FY2023-25 while revenue rose 29%).
What do we forecast?Revenue growth of 16% demonstrated; a terminal operating margin of 8%; an exit multiple of 18.6x.
What does Street forecast?Not determined — no consensus estimates are joined to this record
Where do we differ?On revenue growth, the difference between what the price requires and what the business has demonstrated is -17.4 percentage points.
What is it worth?Not determined — Striking a target from unverified inputs is the error being corrected.
Why now?Date not announced — no dated event that would resolve the disagreement is on file

What must go right

  1. By Q4 FY2026, reports ~Aug 2026Revenue at or above $1,215m -- below the Q3 FY2026 actual, i.e. the first sequential decline of the cycle, against a consensus of $1,275.1m.Where it stands: Not determined — no current reading of this metric is on file
  2. By any two consecutive quarters through FY2027Gross margin at or above 11.5% for TWO CONSECUTIVE quarters (TTM 12.03%; FY2023->FY2025 already 12.71% -> 12.09%). Tests the one thing the whole valuation rests on: that FN keeps its conversion fee while scaling.Where it stands: Not determined — no current reading of this metric is on file
  3. By FY2027 10-K, ~Aug 2027 (testable at the FY2026 10-K, ~Aug 2026)The >=10% customer group's combined share of revenue at or below 65%, and any single customer at or below 33% -- concentration compounding rather than diversifying.Where it stands: Not determined — no current reading of this metric is on file

Catalysts and falsifiers

Date or windowEventThesis confirmed ifThesis weakened or refuted if
Q4 FY2026, reports ~Aug 2026Revenue below $1,215m -- below the Q3 FY2026 actual, i.e. the first…Revenue at or above $1,215m -- below the Q3 FY2026 actual, i.e. the first sequential decline of the cycle, against a…Revenue below $1,215m -- below the Q3 FY2026 actual, i.e. the first sequential decline of the cycle, against a…
any two consecutive quarters through FY2027Gross margin below 11.5% for TWO CONSECUTIVE quarters (TTM 12.03%…Gross margin at or above 11.5% for TWO CONSECUTIVE quarters (TTM 12.03%; FY2023->FY2025 already 12.71% -> 12.09%).…Gross margin below 11.5% for TWO CONSECUTIVE quarters (TTM 12.03%; FY2023->FY2025 already 12.71% -> 12.09%). Tests the…
FY2027 10-K, ~Aug 2027 (testable at the FY2026 10-K, ~Aug 2026)The >=10% customer group's combined share of revenue above 65%, OR…The >=10% customer group's combined share of revenue at or below 65%, and any single customer at or below 33%…The >=10% customer group's combined share of revenue above 65%, OR any single customer above 33% -- concentration…
any quarter through FY2027Datacenter-interconnect revenue declining year on year in any quarter…Neither leg of the condition opposite is met at this dateDatacenter-interconnect revenue declining year on year in any quarter (Q3 FY2026: $196.9m, +90.4% YoY). DCI is the…

Risk and sell discipline

Impairment case

Co-packaged optics removes the assembly step FN is paid for. FN is paid to assemble discrete optical modules; CPO integrates the optical engine into the switch or XPU package and that content migrates to ASIC advanced packaging -- OSAT and foundry -- not to an optical contract manufacturer in Thailand. Not hypothetical: the sell side put CPO to FN nine times in prepared remarks and five times in Q&A in the most recent quarter, the highest CPO intensity in the optical cluster. Amplified by customer concentration that WORSENED and was not recorded by the prior memo: the Q3 FY2026 10-Q discloses FOUR customers each >=10% of revenue totalling 58.1% of 9M FY2026, against TWO totalling 47.5% a year earlier. Last named split, FY2025 10-K Note 20: NVIDIA 27.6%, Cisco 18.2%.

Estimated probability 22%, against the 20% level at which the position would be resized. It sits above that level, so this case could not be carried at full size.

Fundamental invalidation

Falsifiable and fundamental — not one of them is a price condition.

Price-based risk trigger

A daily close below $362.53 triggers an immediate review of the thesis and pauses additional buying. It is not an automatic sell unless a separate fundamental invalidation condition has been breached.

Upside sell discipline

The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.

Investment criteria

CriteriaStatusInvestment meaning
QualityNot metIs the business worth owning under its declared economic type?
ValuationNot metIs the operating path required by today's price achievable?
LiquidityMetCan the intended position be built and exited in the right vehicle?
DownsideMetCo-packaged optics removes the assembly step FN is paid for.
MomentumNot determinedDoes price action support or complicate entry timing? Not established on the evidence on file.
CatalystNot determinedIs there a dated event that resolves the disagreement? Not established on the evidence on file.
ConsensusNot determinedIs the house-versus-Street disagreement identified and quantified? Not established on the evidence on file.

Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.

Bottom line

The gap between what today's price requires and what the business has demonstrated is -17.4 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: co-packaged optics removes the assembly step FN is paid for. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $362.53, which forces an immediate review.